Daiichi Sankyo reported JPY101.6B in EBITDA for its fiscal quarter ending in March of 2025.


Ebitda Change Date
Astellas Pharma JPY 140.34B 29.56B Jun/2025
Chugai Pharma 144.8B 13.52B Jun/2025
Daiichi Sankyo JPY 101.6B 22.81B Mar/2025
Eisai JPY 8.81B 28.8B Mar/2025
Kyowa Hakko Kirin JPY 19.04B 4.59B Jun/2025
M3 JPY 22.88B 7.05B Jun/2025
Otsuka Holdings JPY 134.59B 9.43B Jun/2025
Shionogi JPY 40.11B 7.53B Jun/2025
Sumitomo Dainippon JPY 26.24B 3.95B Jun/2025
Takeda JPY 366.2B 238.06B Jun/2025
Terumo JPY 77.07B 31.43B Jun/2025